Diligence memo · auto-generated · as of July 2, 2026
BioHorizons, Inc.
BioHorizons, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
BioHorizons, Inc. operates in Other Health Care, based in BIRMINGHAM.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BioHorizons, Inc. has raised $64M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $50M on 2011-06-30.
Most recent recorded round closed around 2012-12-18.
Valuation (modeled)modeled
Provath models BioHorizons, Inc. at approximately $34M (range $5.5M–$90M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.03× the median modeled value of Series C Other Health Care companies in 2010–2012 (24 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 9 months.
Last raise 13.5 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 8.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 94% of Other Health Care peers (5377 compared).
Modeled value ranks above 61% of those peers.
Closest niche peers: Castlight Health, Inc., Msd Parent Corp., Pentec Healthcare Infusions, Inc., OraPharma Topco Holdings, Inc., Cameron Health, Inc..
Peoplefiled
16 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.